Loading market dashboard
Lyell Immunopharma, Inc.
LYELHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Lyell Immunopharma, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $280.00M | $280.00M - $280.00M | -$280.00M | -$4.065 | 1 |
| Dec 2029 | $190.23M | $190.23M - $190.23M | -$190.23M | -$5.115 | 2 |
| Dec 2028 | $56.65M | $56.65M - $56.65M | -$56.65M | -$7.07 | 3 |
| Dec 2027 | $9.44M | $9.44M - $9.44M | -$9.44M | -$7.99 | 6 |
| Dec 2026 | $11.7K | $11.7K - $11.7K | -$11.7K | -$7.683 | 6 |
| Dec 2025 | $36.2K | $36.2K - $36.2K | -$36.2K | -$10.53 | 3 |
| Dec 2024 | $49.0K | $49.0K - $49.0K | -$49.0K | -$14.60 | 2 |
| Dec 2023 | $54.0K | $54.0K - $54.0K | -$54.0K | -$0.83 | 1 |
| Dec 2022 | $49.32M | $48.90M - $49.74M | -$49.32M | -$17.20 | 1 |
| Dec 2021 | $9.41M | $9.41M - $9.41M | -$9.41M | -$29.436 | 1 |